One thing we rarely discuss is the selling price for
One thing we rarely discuss is the selling price for Leronlimab per dose. As much as Leronlimab in some indications is the only drug that might work and there is no completion, there are other indications where it may be the best or better than what is available. Focusing on the performance is important, but I wonder if pricing has a roll in making the BP industry notice this drug. What if we price Leronlimab cheaper, given the huge population that is just suffering from MASH?
"8 weeks * 1,000,000 patients * $1,000 per vial = $8 billion over 8 weeks for treating merely a very tiny proportion of the patient population out there and only treating them for 1/2 of 1 course."
if we use this example, and add that Cytodyn may have spent $500 million on the development of Leronlimab (just an estimate) we can see that the cost per dose for the million patient for 8 doses is about $63 per to fully pay for development. I have no idea what it costs to actually make Leronlimab but if the dose could be less than $200 per dose we might have real threat to any other drug in this indication.
I would think BP would be not only concerned about greater effectiveness of Leronlimab but also the willingness to sell it for a low cost by Cytodyn could really make BP want to jump in long before it hits the market. just a thought.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Top 5 Most Recently Viewed Articles
Colorado's Landmark Psilocybin Session by The Center Origin The Center Origin has achieved a significant milestone in the field of natural medicine by successfully conducting Colorado's first regulated high-dose psilocybin healing session. This remarkable event follows the center's receipt of Colorado's inaugural legal delivery of tested psilocybin medicine, reflecting...
Continue Reading
The Ether Machine's Exciting Entry into Public Markets The Ether Machine is gearing up for an impressive public launch, backed by an astounding amount of committed capital. This newly formed entity plans to revolutionize institutional access to Ethereum yield by managing one of the largest pools of Ether, anticipated at over 400,000 Ether (ETH). The aim is to provide...
Continue Reading
ConnectM Technology Solutions Achieves Remarkable Financial Growth ConnectM Technology Solutions, Inc. (OTC: CNTM), a dynamic entity within the technology sector, recently shared its financial performance for the period ending September 30, 2025. The report highlighted significant revenue growth and ongoing efforts to strengthen its balance sheet, marking an impressive...
Continue Reading
Understanding Belden's Upcoming Earnings Release Insights Belden (NYSE: BDC) is gearing up to share its quarterly earnings report soon. Investors are highly attentive to the expectations leading up to the announcement, which carries considerable weight in market reactions. Understanding what to anticipate can provide crucial insight into how the stock might respond....
Continue Reading
Understanding NiSource's Short Interest Trends NiSource Inc (NYSE: NI) has recently seen a notable rise in its short interest, increasing by 11.56% since its last report. As of now, there are 12.09 million shares sold short, which equates to about 3.28% of all available shares for trading. Given the current trading volume, it would take approximately 3.19 days for traders...
Continue Reading